B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections

Vaccine

Volumn 29, Issue 14, 2011, Pages 2523-2529

  Adone, Rosanna ^a   Francia, Massimiliano ^a   Pistoia, Claudia ^a   Pesciaroli, Michele ^a   Pasquali, Paolo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Animal; Brucellosis; Vaccine

Indexed keywords

BRUCELLA VACCINE; GAMMA INTERFERON; PLACEBO;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROLOGY; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLOSIS; FEMALE; INTERFERON-GAMMA; MICE; SPLEEN;

EID: 79952243772     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.072     Document Type: Article

References (65)

1. Adone R., Ciuchini F. Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51. Clin Diagn Lab Immunol 1999, 6:787-790.
2. Adone R., Ciuchini F., Olsen S.C. Field validation of RB51 antigen in a complement fixation test to identify calves vaccinated with Brucella abortus RB51. Clin Diagn Lab Immunol 2001, 8:385-387.
3. Adone R., Ciuchini F., Marianelli C., Tarantino M., Pistoia C., Marcon G., et al. Protective properties of rifampin-resistant rough mutants of Brucella melitensis. Infect Immun 2005, 73:4198-4204.
4. Adone R., Francia M., Ciuchini F. Brucella melitensis B115-based complement fixation test to detect antibodies induced by Brucella rough strains. J Appl Microbiol 2008, 105:567-574.
5. Adone R., Francia M., Ciuchini F. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections. Vaccine 2008, 26:4913-4917.
6. Alton G.G., Elberg S.S. Rev. 1 Brucella melitensis vaccine: a review of ten years of study. Vet Bull 1967, 371:793-800.
7. Alton G.G., Jones L.M., Angus R.D., Verger J.M. Techniques for the brucellosis laboratory 1988, Institute National de la Recherche Agronomique, Paris, France.
8. Álvarez J., Sáezb J.L., García N., Serratc C., Pérez-Sanchoa M., González S., et al. Management of an outbreak of brucellosis due to B. melitensis in dairy cattle in Spain. Res Vet Sci 2010, 10.1016/j.rvsc.2010.05.028.
9. Banai M. Control of small ruminant brucellosis by use of Brucella melitensis Rev. 1 vaccine: laboratory aspects and field observations. Vet Microbiol 2002, 90:497-519.
10. Becker H.N., Belden R.C., Breault T., Burridge M.J., Frankenberger W.B., Nicoletti P. Brucellosis in feral swine in Florida. J Am Vet Med Assoc 1978, 173:1181-1182.
11. Benkirane A. Ovine and caprine brucellosis: world distribution and control/eradication strategies in West Asia/North Africa region. Small Ruminant Res 2006, 62:19-25.
12. Bercovich Z. Maintenance of Brucella abortus-free herds: a review with emphasis on the epidemiology and the problems in diagnosing brucellosis in areas of low prevalence. Vet Q 1998, 20:81-88.
13. Blasco J.M. A review of the use of Brucella melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 1997, 31:275-283.
14. Cloeckaert A., Jacques I., de Wergifosse P., Dubray G., Limet J.N. Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharide. Infect Immun 1992, 60:312-315.
15. Cloeckaert A., Zygmunt M.S., Nicolle J., Dubray G., Limet J.N. O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy. J Gen Microb 1992, 138:1211-1219.
16. Cloeckaert A., Zygmunt M.S., Nicolle J., Dubray G., Limet J.N. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115. J Gen Microb 1993, 139:1551-1556.
17. Corbel M.J. Brucellosis: an overview. Emerg Infect Dis 1997, 3:213-221.
18. Denes B. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia. Acta Vet Hung 1997, 45:33-43.
19. Diaz R., Jones L.M., Wilson J.B. Antigenic relationship of the Gram-negative organism causing canine abortion to smooth and rough Brucellae. J Bacteriol 1967, 93:1262-1268.
20. Edmonds M.D., Samartino L.E., Hoyt P.G., Hagius S.D., Walker J.V., Enright F.M., et al. Oral vaccination of sexually mature pigs with Brucella abortus vaccine strain RB51. Am J Vet Res 2001, 62:1328-1331.
21. EFSA The community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2006. EFSA J 2007, 130:24-106.
22. El Idrissi A.H., Benkirane A., El Maadoudi M., Bouslikhane M., Berrada J., Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech Off Int Epiz 2001, 20:741-747.
23. Elzer P.H., Jacobson R.H., Jones S.M., Nielsen K.H., Douglas J.T., Winter A.J. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 1994, 82:651-658.
24. Ewalt D.R., Prayeur J.B., Rhyan J.C., Geer P.L. Brucella suis biovar 1 in naturally infected cattle: a bacteriological, serological and histological study. J Vet Diagn Invest 1997, 9:417-420.
25. FAO Brucella melitensis in Eurasia and the Middle East. FAO Animal Production and Health Proceedings 2010.
26. Franco M., Mulder M., Gilman R., Smits H.L. Human brucellosis. Lancet Infect Dis 2007, 7:775-786.
27. Garin-Bastuji B., Delcueillerie F. Le brucelloses humaine et animals en France en l'an 2000. Situation épidémiologique-programmes de contrôle et de eradication. Med Mal Infect 2001, 31:202-216.
28. Godfroid F., Cloeckaert A., Taminiau B., Danese I., Tibor A., de Bolle X., et al. Genetic organization of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M (wkb). Res Microbiol 2000, 151:655-668.
29. Huang L.-Y., Krieg A.M., Eller N., Scott D.E. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide and heat-inactivated bacteria. Infect Immun 1999, 67:6257-6263.
30. Hutton T., DeLiberto T., Owen S., Morrison B. Disease risk associated with increasing feral swine numbers and distribution in the United States 2006, Midwest Assoc. of Fish and Wildlife Agencies.
31. Jiang X., Baldwin C.L. Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun 1993, 61:124-134.
32. Jiménez de Bagüés M.P., Barberán M., Marín C.M., Blasco J.M. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 1995, 13:301-304.
33. Kahler S.C. Brucella melitensis infection discovered in cattle for first time, goats also infected. J Am Vet Med Assoc 2000, 216:648.
34. Kolar J. FAO/WHO/OIE round table on the use of Rev1 vaccine in small ruminants and cattle. Some experience from brucellosis control with Rev1 vaccine in a heavily infected country - Mongolia 1995, 77-81. CNEVA, Alfort. B. Garin-Batuji, A. Benkirane (Eds.).
35. Marianelli C., Ciuchini F., Tarantino M., Pasquali P., Adone R. Molecular characterization of the rpob gene in Brucella species: new potential molecular markers for genotyping. Microbes Infect 2006, 8:860-865.
36. Marin C.M., Barberan M., Jimenez de Bagues M.P., Blasco J.M. Comparison of subcutaneous and conjunctival routes of Rev1 vaccination for the prophylaxis of Brucella ovis infection in rams. Res Vet Sci 1990, 48:209-215.
37. Mason R.J., Fleming P.J.S. Serologic survey for Brucella antibodies in feral pigs from eastern Australia. Aust Vet J 1999, 77:331-332.
38. Meyer M.E., Nelson C.J. Persistence of Brucella abortus strain 19 infection in immunized cattle. Proceedings of the United States Animal Health Association 1969, 159-165.
39. Minas A., Minas M., Stournara A., Tselepidis S. The effects of Rev1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med 2004, 64:41-47.
40. Nicoletti P., Winter A.J. The immune response to Brucella abortus-the cell-mediated response to infections. Animal brucellosis 1990, 83-96. CRC Press, Boston, MA. K. Nielsen, J.R. Duncan (Eds.).
41. Nicoletti P. The control of brucellosis - a veterinary responsibility. Saudi Med J 1992, 13:10-13.
42. Office International des Epizooties Manual of diagnostic tests and vaccines for terrestrial animals 2008, Office International des Epizooties, Paris, France Bovine brucellosis, p. 624-659.
43. OIE (2000-2008). Reported cases of human brucellosis in selected Mediterranean and Middle East Countries. Official reports; OIE/World Annual Health Reports.
44. Olsen S.C., Evans D., Hennager S.G., Cheville N.F., Stevens M.G. Serologic responses of calfhood vaccinated cattle to Brucella abortus strain RB51. J Vet Diagn Invest 1996, 8:451-454.
45. Olsen S.C., Stoffregen W.S. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines 2005, 4:915-928.
46. Olsen S., Tatum F. Bovine brucellosis. Vet Clin Food Anim 2010, 26:15-27.
47. Olsen S.C., Hennager S.G. Immune response and protection against experimental Brucella suis biovar 1 challenge in non-vaccinated or RB51-vaccinated cattle. Clin Vaccine Immunol 2010, 10.1128/CVI.00326-10.
48. Pappas G., Akritidis N., Bosilkovski M., Tsianos E. Brucellosis. N Engl J Med 2005, 352:2325-2336.
49. Pasquali P., Adone R., Gasbarre L.C., Pistoia C., Ciuchini F. Mouse cytokine profiles associated with Brucella abortus RB51vaccination or Brucella abortus 2308 infection. Infect Immun 2001, 69:6541-6544.
50. Pasquali P., Adone R., Gasbarre L.C., Pistoia C., Ciuchini F. Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice. Clin Diagn Lab Immunol 2002, 9:491-492.
51. Pasquali P., Adone R., Pistoia C., Petrucci P., Ciuchini F. Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308. Infect Immun 2003, 71:2326-2330.
52. Roop I.I.R.M., Preston-Moore D.P., Bagchi T., Schurig G.G. Rapid identification of smooth Brucella species with a monoclonal antibody. J Clin Microbiol 1987, 25:2090-2093.
53. Roth F., Zinsstag J., Orkhon D., Chimed-Ochir G., Hutton G., Cosivi O., et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull WHO 2003, 81:867-876.
54. Samaha H., Al-Rowaily M., Khoudair R.M., Ashour H.M. Multicenter study of brucellosis in Egypt. Emerg Infect Dis 2008, 14:1916-1918.
55. Schurig G.G., Martin Roop R., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol 1991, 28:171-188.
56. Seung-Bin Cha, Nabin Rayamajhi, Mi-Lan Kang, Won-Jung Lee, Min-Kyoung Shin, Han-Sang Yoo Comparative study of gamma interferon production in mice immunized with outer membrane proteins and whole bacteria of Brucella abortus. Jpn J Infect Dis 2010, 63:49-51.
57. Stevens M.G., Olsen S.C., Palmer M.V., Pugh G.W. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51. Infect Immun 1996, 64:4534-4541.
58. Stoffregen W.C., Olsen S.C., Wheeler C.J. Diagnostic characterization of a feral swine herd enzootically infected with Brucella. J Vet Diagn Invest 2007, 19:227-237.
59. Thomas E.L., Bacewell C.D., Corbel M.J. Characterization of Brucella abortus strain 19 cultures isolated from vaccinated cattle. Vet Rec 1981, 108:90-93.
60. USDA, APHIS, NVSL Standard operating procedures. SOP-Sero-1022, 1024, 1025, 1026, 1027 and 1051 2010, National Veterinary Services Laboratory, 1920 Dayton Avenue, Ames, IA 500010.
61. Vemulapalli R., Contreras A., Sanakkayala N., Sriranganathan N., Boyle S.M., Schurig G.G. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vet Microb 2004, 102:237-245.
62. Verger J.M., Grayon M., Zundel E., Lechopier P., Olivier- Bernardin V. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev.1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Vaccine 1995, 13:191-196.
63. Vizcaino N., Fernandez-Lago L. A rapid and sensitive method for the identification of Brucella species with a monoclonal antibody. Res Microbiol 1992, 143:513-518.
64. Brucellosis in humans and animals 2006, World Health Organization, Geneva. World Health Organization (Ed.).
65. Xie Xin Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine. Vaccine 1986, 4:212-216.